References
- Aschele C, Lonardi S, Monfardini S (2002). Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer. Cancer Treat Rev, 28, 27-47. https://doi.org/10.1053/ctrv.2002.0253
- Cheng X, Kigawa J, Minagawa Y, et al (1997). Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy. Cancer, 79, 521-7. https://doi.org/10.1002/(SICI)1097-0142(19970201)79:3<521::AID-CNCR14>3.0.CO;2-5
- Covault J, Abreu C, Kranzler H, Oncken C (2003). Quantitative real-time PCR for gene dosage determinations in microdeletion genotypes. Biotechniques, 35, 594-8.
- Depeille P, Cuq P, Mary S, et al (2004) Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects. Mol Pharmacol, 65, 897-905. https://doi.org/10.1124/mol.65.4.897
- Funke S, Brenner H, Chang-Claude J (2008) Pharmacogenetics in colorectal cancer: A systematic review. Pharmacogenomics, 9, 1079-99. https://doi.org/10.2217/14622416.9.8.1079
- He Y, Hoskins JM, McLeod HL (2011). Copy number variants in pharmacogenetic genes. Trends Mol Med, 17, 244-51. https://doi.org/10.1016/j.molmed.2011.01.007
- Imsamran W, Chaiwerawattana A,Wiangnon S, et al (2015). Cancer in Thailand Vol VIII. Bangkok: New Thammada Press (Thailand) Co., Ltd.
- Lai CY, Hsieh LL, Sung FC, (2013). Tumor site- and stage-specific associations between allelic variants of glutathione S-transferase and DNA-repair genes and overall survival in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. PLoS One, 8, e69039. doi:10.1371/journal.pone. 0069039.
- Mccarroll SA, Altshuler DM (2007). Copy-number variation and association studies of human disease. Nature Genet, 39, 37-42. https://doi.org/10.1038/ng2080
- Mohelnikova-Duchonova B, Melichar B, Soucek P, (2014). FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy. World J Gastroenterol, 20, 10316-630. https://doi.org/10.3748/wjg.v20.i30.10316
- Norskov MS, Frikke-Schmidt R, Loft S, Tybjaerg-Hansen A, (2009). High-throughput genotyping of copy number variation in glutathione S-transferases M1 and T1 using real-time PCR in 20,687 individuals. Clin Biochem, 42, 201-9. https://doi.org/10.1016/j.clinbiochem.2008.10.020
- Pongtheerat T, Chaksangchaichot P, Saelee P, (2013). Prognosis in Thai colorectal-cancer patients with GSTM1 and GSTT1 copy number variation. Eur J Oncol, 18, 189-95.
- Rebbeck TR, (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 6, 733-43.
- Satta T, Isobe K, Yamauchi M, Nakashima I, Takagi H, (1992). Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer. Cancer, 69, 941-46. https://doi.org/10.1002/1097-0142(19920215)69:4<941::AID-CNCR2820690418>3.0.CO;2-H
- Seo BG, Kwon HC, Oh SY, et al (2009). Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI. Oncol Rep, 22, 127-36.
- Sinicrope FA, Foster NR, Thibodeau SN, et al (2011). DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst, 103, 863-75. https://doi.org/10.1093/jnci/djr153
- Sprenger R, Schlagenhaufer R, Kerb R, et al (2000). Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics, 10, 557-65. https://doi.org/10.1097/00008571-200008000-00009
- Stoehlmacher J, Park DJ, Zhang W, et al. (2002). Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst, 94, 936-42. https://doi.org/10.1093/jnci/94.12.936